31 Mar 2024
Assets15.89
Total Income15.90
EBITDA7.09
Profit After Tax3.81
NET Worth8.67
Reserves and Surplus8.54
Total Borrowing3.81
At a glance
Updated 2026-09-10Invicta Diagnostic is a SME IPO with an issue size of ₹28.12 crore, proposed for listing on NSE SME. The issue structure includes a fresh issue of ₹26.71 crore.
Issue details
Listing atNSE SME
Issue typeBook Build Issue
Issue size₹28.12 Cr
Fresh issue₹26.71 Cr
Face value₹10
Price band₹80.00–₹85.00
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗QIB3.51×
sHNI6.27×
bHNI5.32×
NII / HNI5.32×
Retail3.44×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Max) | 2 | 3200 | ₹272,000 |
| S-HNI (Min) | 3 | 4800 | ₹408,000 |
| S-HNI (Max) | 7 | 11200 | ₹952,000 |
| B-HNI (Min) | 8 | 12800 | ₹1,088,000 |
Company
Use of proceeds
| Object | Amount |
|---|---|
| Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra | ₹21.11 Cr |
| General Corporate Purposes | ₹4.07 Cr |
| Issue Expenses | ₹2.94 Cr |
| Total | ₹28.12 Cr |
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue17.08₹ Cr · -43.4% vs prior year
EBITDA6.77₹ Cr · -26.4% vs prior year
PAT4.08₹ Cr · -17.2% vs prior year
Assets34.90₹ Cr · +64.5% vs prior year
Net Worth23.68₹ Cr · +74.1% vs prior year
Borrowing3.72₹ Cr · +5.1% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2025
Assets21.22
Total Income30.18
EBITDA9.20
Profit After Tax4.93
NET Worth13.60
Reserves and Surplus5.18
Total Borrowing3.54
30 Sep 2025
Assets34.90
Total Income17.08
EBITDA6.77
Profit After Tax4.08
NET Worth23.68
Reserves and Surplus14.42
Total Borrowing3.72
KPIs
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 44.28% |
| ROCE | 42.00% |
| Debt / Equity | 0.26% |
| RoNW | 36.25% |
| PAT Margin | 16.38% |
| EBITDA Margin | 30.57% |
| Price to Book Value | 5.26 |
Valuation & shareholding
Pre-IPO EPS5.86
Post-IPO EPS6.50
Pre-IPO P/E14.51
Post-IPO P/E13.08
Promoter holding pre90.52%
Promoter holding post66.69%
Market cap₹106.86 Cr.
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Invicta Diagnostic IPO | — | 21.68 x | — | — |
| Pramodini Medicare IPO | — | 14.97 x | — | — |
| Qualitek Labs IPO | — | 18.34 x | — | — |
Issue expenses
| Expense | Amount |
|---|---|
| Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra | ₹21.11 Cr |
| General Corporate Purposes | ₹4.07 Cr |
| Issue Expenses | ₹2.94 Cr |
| Total | ₹28.12 Cr |
Registrar & lead managers
Registrar
Bigshare Services Pvt.Ltd.Lead managers
- Socradamus Capital Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-10.
IPO UPDATE ALERTS
Register for IPO Updates →Track Invicta Diagnostic without missing an update
Register for subscription, GMP, allotment and listing notifications.